Tumor rim cells: From resistance to vascular targeting agents to complete tumor ablation
Current vascular targeting strategies pursue two main goals: anti-angiogenesis agents aim to halt sprouting and the formation of new blood vessels, while vascular disrupting agents along with coaguligands seek to compromise blood circulation in the vessels. The ultimate goal of such therapies is to...
Saved in:
| Main Authors: | Khaled Seidi, Rana Jahanban-Esfahlan, Nosratollah Zarghami |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2017-03-01
|
| Series: | Tumor Biology |
| Online Access: | https://doi.org/10.1177/1010428317691001 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Applications of Hydroxyapatite-Based Polymeric Scaffolds in Bone Tissue Engineering: An Update
by: Nazanin Amiryaghoubi, et al.
Published: (2024-12-01) -
For and against tumor microenvironment: Nanoparticle-based strategies for active cancer therapy
by: Soroush Karimi, et al.
Published: (2025-04-01) -
Platelet hitchhiking vascular-disrupting agents for self-amplified tumor-targeting therapy
by: Hongyu Chu, et al.
Published: (2025-03-01) -
A Review on the Hazardous Materials Removal Using Activated Carbons Derived from Walnut (Juglans regia L.) Shell
by: A. Jahanban-Esfahlan, et al.
Published: (2020-03-01) -
Natural medicines target tumor vascular microenvironment to inhibit tumor
by: Yirui Lu, et al.
Published: (2025-11-01)